Discovery Services

Integrated Drug Discovery

"In preparing for battle I have always found that plans are useless, but planning is indispensible."
  – Dwight D. Eisenhower

  • Early Discovery
    • Target Biology
    • Cell Line Development
    • Assay Development
    • Computational Chemistry
  • Hit Identification
    • Assay Development
    • High Throughput Screening
    • Secondary Screening
    • Orthogonal Screening
    • Profiling
    • Medicinal Chemistry
    • In vitro early ADME
    • Synthetic chemistry
  • Hit to Lead
    • MOA
    • Potency/Selectivity
    • In vitro safety
  • Lead Optimization
    • Potency/selectivity optimization
    • Safety

Drug discovery isn't "rocket science" – in that it is more like a battle than an engineering project. Effective campaigns are prosecuted by interdisciplinary teams working in tight communication and continuously adjusting to events and conditions. Physical, temporal or cultural distance compromises both quality and speed of the effort. For these reasons, early discovery is most effective in tight-knit teams reviewing live data in real time and working together to overcome obstacles and solve problems.

At Icagen, a partner will find everything they need under one roof, in addition to a different kind of scientist. Scientists at Icagen not only have strong expertise in their field but also offer a unique translational knowledge of all fields, demonstrating that true integration leads to the discovery of strong drug candidates. This is how Icagen chemists, biologists and computational scientists have worked for together for nearly two decades. At Icagen, drug discovery occurs in a web of biology, chemistry, structural biology and in silico modeling, in which reevaluations and readjustments happen seamlessly and in real time.

The experience of our scientists, the agility of our teams, and the transparency of our communications when combined offer a turnkey solution for your most challenging programs.